biospecimen_aliquot__bcr_aliquot_barcode	tcga-d8-a27k-01a-11d-a16d-09
biospecimen_aliquot__bcr_aliquot_uuid	09fa0bc7-acb3-45b0-b687-977869c31d12
biospecimen_aliquot__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_aliquot__bcr_sample_barcode	tcga-d8-a27k-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0113421789
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.09
biospecimen_aliquot__date_of_shipment	2011-06-14
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	3
biospecimen_aliquot__plate_id	a16d
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	3.60
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.85
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-d8-a27k-01a-11d
biospecimen_analyte__bcr_analyte_uuid	085f9cd8-5031-4880-88c7-1e6122e3d3f4
biospecimen_analyte__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_analyte__bcr_sample_barcode	tcga-d8-a27k-01a
biospecimen_analyte__concentration	0.17
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-d8-a27k
biospecimen_diagnostic_slides__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-d8-a27k-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	25af7928-046b-45bf-bad6-f34156203f5a
biospecimen_normal_control__bcr_patient_barcode	tcga-d8-a27k
biospecimen_normal_control__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_portion__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_portion__bcr_portion_barcode	tcga-d8-a27k-01a-11
biospecimen_portion__bcr_portion_uuid	a2de4a7c-773e-4c48-8268-92edc055e189
biospecimen_portion__bcr_sample_barcode	tcga-d8-a27k-01a
biospecimen_portion__date_of_creation	2011-05-24
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-d8-a27k-01a-11d
biospecimen_protocol__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_protocol__bcr_sample_barcode	tcga-d8-a27k-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_sample__bcr_sample_barcode	tcga-d8-a27k-01a
biospecimen_sample__bcr_sample_uuid	9e163b4c-d624-4c71-9d68-8f002aee6fec
biospecimen_sample__days_to_collection	77
biospecimen_sample__initial_weight	190
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-d8-a27k.6b2adf84-5cea-430a-87dd-5c2ec24c6e90.pdf
biospecimen_sample__pathology_report_uuid	6b2adf84-5cea-430a-87dd-5c2ec24c6e90
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_shipment_portion__bcr_sample_barcode	tcga-d8-a27k-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	d8b985f8-cbad-42bb-995c-42d7f8221ea4
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17l
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-d8-a27k-01a-21-a17l-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
biospecimen_slide__bcr_sample_barcode	tcga-d8-a27k-01a
biospecimen_slide__bcr_slide_barcode	tcga-d8-a27k-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	b8d6df65-efe5-4317-b903-b93ec05aaa5f
biospecimen_slide__image_file_name	tcga-d8-a27k-01a-01-ts1.b8d6df65-efe5-4317-b903-b93ec05aaa5f.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	10
biospecimen_slide__percent_tumor_cells	90
biospecimen_slide__percent_tumor_nuclei	85
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-d8-a27k
biospecimen_tumor_sample__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
clinical_drug__bcr_drug_barcode	tcga-d8-a27k-d29589
clinical_drug__bcr_drug_uuid	08ce6ce2-b1ee-4e48-afcd-df600c649e6e
clinical_drug__bcr_patient_barcode	tcga-d8-a27k
clinical_drug__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
clinical_drug__form_completion_date	2012-3-26
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin+cyclophosphamid
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg/m2
clinical_drug__pharmaceutical_tx_ended_days_to	117
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	49
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	60+600
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	240+2400
clinical_follow_up__bcr_followup_barcode	tcga-d8-a27k-f29588
clinical_follow_up__bcr_followup_uuid	060aca7e-17c2-4c0f-893f-068b65ed5256
clinical_follow_up__bcr_patient_barcode	tcga-d8-a27k
clinical_follow_up__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-3-26
clinical_follow_up__last_contact_days_to	287
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	47
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-d8-a27k
clinical_patient__bcr_patient_uuid	7f97971b-2818-4e4b-9c9e-7c0246f9484c
clinical_patient__birth_days_to	-17426
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	manual counting
clinical_patient__er_positivity_scale_other	>75%
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-7-18
clinical_patient__gender	female
clinical_patient__her2_ihc_score	1+
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2011
clinical_patient__last_contact_days_to	119
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	17
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	fine needle aspiration biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a27k
clinical_patient__pr_positivity_define_method	manual counting
clinical_patient__pr_positivity_scale_other	>75%
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	yes
clinical_patient__race	white
clinical_patient__retrospective_collection	no
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	d8
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A27K-01A-11D-A16D-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-D8-A27K-01A-11D-A16D-09.bed.meta
manually_curated__id	tcga-d8-a27k-01a-11d-a16d-09
manually_curated__md5sum	01a6845610e391eada8da7aa615dcd11
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	09fa0bc7-acb3-45b0-b687-977869c31d12
manually_curated__tumor_tag	brca
